Key Takeaways ACB's medical cannabis revenues rose nearly 25% to C$135.3M, making up 72% of net revenues.Aurora Cannabis saw higher international sales lift margins and helped adjusted EBITDA jump 92% to C$26.2M.ACB is scaling back low-margin consumer cannabis as competition and price pressure weigh on that segment.Aurora Cannabis (ACB) sits at the intersection of a shifting regulatory landscape as the Trump administration moves to reclassify marijuana. While the decision marks a constructive step for the c ...

Potential Schedule III Status Could Improve Legal Clarity for Patients Traveling from Colombia to the United States with Prescribed Medical Cannabis CALI, COLOMBIA / ACCESS Newswire / December 22, 2025 / Sannabis S.A.S., a federally licensed and regulated medical cannabis operator in Colombia, today issued commentary on the ongoing U.S. federal process to reschedule marijuana under the Controlled Substances Act ("CSA") and the potential legal, policy, and international trade implications such a change could ...

I'd like to see the money that is going to the insurance companies by the hundreds of billions of dollars. The stocks are up through the roof over a fairly short period of time because they're getting vast amounts of money. I want that money to go to the people directly and let the people buy their own health care and uh they'll get much better health care than they get with the unaffordable care act. let the money go directly to the people and let them buy their own healthcare.>> President Trump along with ...

Tilray Brands (NASDAQ:TLRY), a global medical cannabis producer, closed Thursday at $12.34, down 4.2%. Tilray Brands IPO'd in 2018 and has fallen 94% since going public. Trading volume reached 66.7 million shares, coming in 514% above its three-month average of 10.9 million shares. How the markets moved today Thursday’s session saw cannabis names reacting to a Trump executive order reclassifying marijuana, and investors are watching how the U.S. cannabis industry will evolve. The S&P 500 (SNPINDEX:^GSPC) ...

Core Insights - Canadian cannabis stocks are gaining attention as sector sentiment improves, with significant exposure to the U.S. market through brands and partnerships [1] - The U.S. cannabis industry is expanding, with total sales exceeding $32 billion annually and projections to surpass $50 billion by 2030, keeping Canadian operators relevant [1] - Renewed discussions on federal cannabis reform and regulatory changes are creating momentum for Canadian cannabis stocks, which often react sharply to U.S. policy developments [1] Company Summaries Tilray Brands (TLRY) - Tilray is a diversified cannabis and consumer products company with operations in cultivation, processing, and branded product distribution, expanding into beverages and wellness products for revenue stability [3][6] - The company has exposure to the U.S. market through hemp-derived products and THC offerings, with strategic partnerships enhancing national distribution [6] - Financially, Tilray is navigating a challenging environment with modest year-over-year revenue growth, unprofitability, and improved adjusted margins across segments [7] Canopy Growth (CGC) - Canopy Growth is a prominent Canadian cannabis producer with a broad portfolio of adult-use and medical brands, including flower, vapes, edibles, and infused beverages [8][10] - The company maintains indirect exposure to the U.S. market through affiliated entities, allowing participation in the U.S. THC market without direct federal conflict [10] - Recent financial results show operational improvement with increased quarterly revenue and reduced operating expenses, although profitability has not yet been achieved [11] Aurora Cannabis (ACB) - Aurora Cannabis focuses primarily on medical cannabis, operating cultivation and distribution facilities across multiple countries, including Europe and Australia [12][14] - The company has limited direct U.S. cannabis exposure but trades on NASDAQ, providing access for U.S. investors [14] - Recent financial results indicate progress toward stabilization, with increased medical cannabis revenue and improved gross margins, while maintaining solid cash reserves [15]

Core Insights - Marijuana stocks present both short-term and long-term investment opportunities, with current low prices creating a favorable buying environment before the new year [1] - The cannabis market is influenced by reform measures, with speculation rising around potential legislative changes, such as the rescheduling of cannabis to Class 3 [2] - The expansion of cannabis legalization in various states and the growth of markets in Canada and Europe are expected to positively impact marijuana stock trading [3] Company Highlights - **Green Thumb Industries Inc.** reported Q3 2025 revenue of $291.4 million, a 1.6% increase year-over-year, with cash at quarter end totaling $226.2 million and GAAP net income of $23.3 million [10] - **Cresco Labs Inc.** is expanding its operations into Germany, launching its flagship flower brand, which reflects its growth strategy beyond the U.S. market [11][13] - **Verano Holdings Corp.** received a conditional license to operate in Texas, allowing it to cultivate, process, and dispense medical cannabis, pending final approval [14][16]

Core Insights - Herbal Dispatch Inc. has announced a comprehensive Strategic Business Plan for 2026 aimed at driving sustainable growth and enhancing shareholder value, building on its strong historical performance and aiming for significant revenue acceleration while improving gross margins and EBITDA [1][2] Strategic Priorities - **Enhancing Medical Cannabis Sales to Veterans**: The company plans to increase sales in this segment by 200% annually through partnerships with veterans' organizations, development of veteran-specific product bundles, and targeted marketing campaigns. Key performance indicators (KPIs) include 30% year-over-year growth in veteran customer acquisition and maintaining a retention rate above 89% [2][3] - **Expanding Recreational Sales**: Herbal Dispatch aims for 40% year-over-year growth in recreational sales by securing listings with additional provincial cannabis wholesalers and expanding SKU counts in British Columbia from 44 to over 100. KPIs include entering new provinces and boosting British Columbia's market share to 15% [2][5] - **Growing B2B Exports**: The company targets tripling export volumes by 2028, focusing on strengthening partnerships in existing markets and entering new markets. KPIs include 100% year-over-year export revenue growth and adding 2-3 new markets annually [5][6] - **Increasing Investor Awareness**: Herbal Dispatch will engage specialized investor relations and marketing firms to enhance liquidity and attract institutional investors, including quarterly webinars and updated investor materials [6][10] Market Position - Herbal Dispatch holds a unique position among Canadian public cannabis companies, with the longest growth runway in the sector. The company is positioned to simultaneously double medical sales and provincial footprint while tripling exports, which are opportunities that competitors have already exhausted [7][8] Execution Strategy - To execute its strategic priorities, Herbal Dispatch has engaged a coordinated team of agencies, allocating approximately CAD $410,000 for these initiatives, funded from existing working capital [12][13]

Core Insights - MariMed Inc. has launched an initiative featuring an original song inspired by U.S. Army veteran Ryan Taylor, highlighting the company's commitment to veteran-focused initiatives and the positive impact of medical cannabis on veterans' lives [1][4]. Group 1: Initiative Overview - The initiative is inspired by Ryan Taylor's transformative experience with medical cannabis, which provided him relief from the physical and emotional wounds of combat [1][4]. - The song, titled "Thrive: Anna," will be played in-store across all 13 Thrive Dispensary locations in multiple states, including Massachusetts, Ohio, Delaware, Maryland, and Illinois [2]. Group 2: Community Engagement - Before the song airs, a recorded introduction from a veteran team member will provide context about the song and recognize FreedomSingsUSA, a nonprofit that helps veterans share their stories through music [3]. - MariMed will make a donation to FreedomSingsUSA in honor of Ryan Taylor, further supporting veteran initiatives [3]. Group 3: Company Background - MariMed Inc. is recognized as a leading multi-state cannabis operator, known for its innovative cultivation, production, and retail facilities [6]. - The company has a portfolio of award-winning cannabis brands, which are well-regarded by consumers across the country [6].

Core Insights - Aurora Cannabis Inc. has appointed Kerry Miller as Managing Director for Australia and New Zealand, effective January 15, 2026, to drive growth in these markets [1][2] Group 1: Leadership Appointment - Kerry Miller brings 35 years of experience in consumer packaged goods, with a notable 25-year tenure at Reckitt Benckiser and nearly 10 years at Unilever, where he led global initiatives and transformation programs [3] - Miller expressed enthusiasm about joining Aurora at a pivotal moment for the company, focusing on expanding access to medical cannabis and enhancing innovation and partnerships [2] Group 2: Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4] - The company offers a diverse portfolio of brands, including adult-use brands like Drift and San Rafael '71, and medical brands such as MedReleaf and CanniMed [4] - Aurora also holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [4]

Core Viewpoint - The outcome of the Phase I conditional medical license awards has no impact on the company's financial performance, outlook, or strategy, reaffirming its commitment to the Texas cannabis industry [1][2]. Company Overview - Village Farms International, Inc. is a large-scale, vertically-integrated supplier of high-value, plant-based Consumer Packaged Goods, leveraging decades of experience in Controlled Environment Agriculture [3]. - The company has a strong foundation as a leading fresh produce supplier in the US and Canada and is now focusing on high-growth cannabinoid opportunities while maintaining its produce assets [3]. Texas Operations - Village Farms owns 2.2 million square feet (50 acres) of greenhouse assets in West Texas and plans to have the same amount in production at its Delta, BC greenhouses by the end of 2026 [2]. - The company also owns 950 acres of unoccupied farmland in Marfa, Texas, selected for its favorable growing climate for controlled environment agriculture [2]. Canadian Operations - In Canada, the company's subsidiary, Pure Sunfarms, is one of the largest cannabis operations globally, with 2.2 million square feet of greenhouse production and is recognized as a low-cost producer [4]. - Village Farms owns an additional 2.6 million square feet of greenhouse capacity in Canada for future expansion and holds an 80% stake in Rose LifeScience, a leader in cannabis product commercialization [4]. International Expansion - The company is targeting selected legal cannabis opportunities internationally, exporting medical cannabis from its EU GMP certified facility in Canada to markets such as Germany, the UK, Israel, Australia, and New Zealand [5]. - Village Farms is expanding its export business and making investments in international production assets, including a license to grow and distribute recreational cannabis in the Netherlands [5]. U.S. Market Strategy - In the U.S., the wholly-owned Balanced Health Botanicals is a leading CBD and hemp-derived brand, and the company plans to enter the U.S. THC market using its Texas-based greenhouse assets [6]. Renewable Energy Initiatives - Village Farms Clean Energy, in partnership with Terreva Renewables, generates renewable natural gas from landfill gas at its Delta RNG facility, receiving royalties on all generated revenue [7].